Dr. Tahseen Mozaffar is a Professor of Neurology and Pathology and Laboratory Medicine and the former Founding Director of the Division of Neuromuscular Disorders. Dr. Mozaffar serves as chair of one of the biomedical committees  and is the Associate Director for the Center for Translational Sciences Award (CTSA) at University of California, Irvine. He was the Principal Investigator for UCI-NEXT, the NeuroNEXT award to the University of California, Irvine, one of 25 such NeuroNEXT sites funded by the NINDS/NIH. He is also the Lead Investigator for a multicenter NIH/NIAMS funded Natural History Study in sIBM (INSPIRE-IBM), which started April 2021.

He graduated medical school at the Aga Khan University in Karachi, Pakistan in 1989 and trained in Neurology and Neuromuscular Disorders at Washington University/Barnes Hospital in St. Louis, MO. Dr. Mozaffar has been at UC Irvine since 2000 where he has built an internationally recognized clinical and research program in Neuromuscular Disorders.

He is actively involved in clinical and translational research in Neuromuscular Disorders, including currently serving as Principal Site Investigator on over a dozen clinical trials in myasthenia gravis, rare and ultra-rare myopathies and in immune myopathies. He has co-authored over 250 peer-reviewed publications and has authored or co-authored over a dozen book chapters and invited reviews. As an expert in these rare and ultra-rare myopathies, he is actively sought as an advisor by pharmaceutical companies for trial design and identifying disease targets.

He is the Director of the nationally recognized Annual UC Irvine Neuromuscular Colloquium, now in its 15^th year of existence and the founding Director of the Annual Neuromuscular Pathology Colloquium, now in its 10^th year.